chr21-45981786-C-G

Variant summary

Our verdict is Benign. The variant received -10 ACMG points: 0P and 10B. BP4_StrongBP6_ModerateBS1

The NM_001848.3(COL6A1):​c.-65C>G variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).

Frequency

Genomes: 𝑓 0.00037 ( 0 hom., cov: 20)
Exomes 𝑓: 0.00088 ( 1 hom. )

Consequence

COL6A1
NM_001848.3 5_prime_UTR

Scores

2

Clinical Significance

Benign criteria provided, single submitter B:1

Conservation

PhyloP100: 0.0150

Publications

1 publications found
Variant links:
Genes affected
COL6A1 (HGNC:2211): (collagen type VI alpha 1 chain) The collagens are a superfamily of proteins that play a role in maintaining the integrity of various tissues. Collagens are extracellular matrix proteins and have a triple-helical domain as their common structural element. Collagen VI is a major structural component of microfibrils. The basic structural unit of collagen VI is a heterotrimer of the alpha1(VI), alpha2(VI), and alpha3(VI) chains. The alpha2(VI) and alpha3(VI) chains are encoded by the COL6A2 and COL6A3 genes, respectively. The protein encoded by this gene is the alpha 1 subunit of type VI collagen (alpha1(VI) chain). Mutations in the genes that code for the collagen VI subunits result in the autosomal dominant disorder, Bethlem myopathy. [provided by RefSeq, Jul 2008]
COL6A1 Gene-Disease associations (from GenCC):
  • collagen 6-related myopathy
    Inheritance: AD, AR Classification: DEFINITIVE Submitted by: ClinGen
  • Bethlem myopathy 1A
    Inheritance: AR, AD Classification: DEFINITIVE, STRONG Submitted by: Genomics England PanelApp, G2P
  • Ullrich congenital muscular dystrophy 1A
    Inheritance: AD, AR Classification: STRONG Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
  • Bethlem myopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Ullrich congenital muscular dystrophy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -10 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.79).
BP6
Variant 21-45981786-C-G is Benign according to our data. Variant chr21-45981786-C-G is described in CliVar as Benign. Clinvar id is 340306.Status of the report is criteria_provided_single_submitter, 1 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.000366 (54/147626) while in subpopulation NFE AF = 0.000687 (46/66912). AF 95% confidence interval is 0.000529. There are 0 homozygotes in GnomAd4. There are 21 alleles in the male GnomAd4 subpopulation. Median coverage is 20. This position passed quality control check.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
COL6A1NM_001848.3 linkc.-65C>G 5_prime_UTR_variant Exon 1 of 35 ENST00000361866.8 NP_001839.2 P12109A0A384P5H7
LOC105372841XR_937803.3 linkn.*220C>G downstream_gene_variant

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
COL6A1ENST00000361866.8 linkc.-65C>G 5_prime_UTR_variant Exon 1 of 35 1 NM_001848.3 ENSP00000355180.3 P12109

Frequencies

GnomAD3 genomes
AF:
0.000366
AC:
54
AN:
147518
Hom.:
0
Cov.:
20
show subpopulations
Gnomad AFR
AF:
0.0000754
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000204
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.0000994
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000687
Gnomad OTH
AF:
0.000494
GnomAD4 exome
AF:
0.000877
AC:
1009
AN:
1151016
Hom.:
1
Cov.:
15
AF XY:
0.000830
AC XY:
478
AN XY:
576014
show subpopulations
African (AFR)
AF:
0.000313
AC:
8
AN:
25566
American (AMR)
AF:
0.000531
AC:
18
AN:
33882
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
22568
East Asian (EAS)
AF:
0.00
AC:
0
AN:
32424
South Asian (SAS)
AF:
0.00
AC:
0
AN:
71466
European-Finnish (FIN)
AF:
0.0000940
AC:
4
AN:
42552
Middle Eastern (MID)
AF:
0.000554
AC:
2
AN:
3608
European-Non Finnish (NFE)
AF:
0.00106
AC:
924
AN:
869752
Other (OTH)
AF:
0.00108
AC:
53
AN:
49198
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.511
Heterozygous variant carriers
0
49
98
146
195
244
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
36
72
108
144
180
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000366
AC:
54
AN:
147626
Hom.:
0
Cov.:
20
AF XY:
0.000292
AC XY:
21
AN XY:
71912
show subpopulations
African (AFR)
AF:
0.0000752
AC:
3
AN:
39916
American (AMR)
AF:
0.000203
AC:
3
AN:
14754
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3426
East Asian (EAS)
AF:
0.00
AC:
0
AN:
4866
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4460
European-Finnish (FIN)
AF:
0.0000994
AC:
1
AN:
10062
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
292
European-Non Finnish (NFE)
AF:
0.000687
AC:
46
AN:
66912
Other (OTH)
AF:
0.000489
AC:
1
AN:
2046
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.519
Heterozygous variant carriers
0
3
7
10
14
17
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000555
Hom.:
0
Bravo
AF:
0.000465

ClinVar

Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Collagen 6-related myopathy Benign:1
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.79
CADD
Benign
8.5
DANN
Benign
0.70
PhyloP100
0.015
PromoterAI
-0.096
Neutral
Mutation Taster
=300/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs535807983; hg19: chr21-47401700; API